Rapid molecular tests for tuberculosis and tuberculosis drug resistance: provider and recipient views

Autor:	Sandy Oliver, Ricky Janssen, Eleanor A Ochodo, Bey-Marrié Schmidt, Nora Engel, Perpetua Wanjiku Karanja, Karen R Steingart
Přispěvatelé:	RS: CAPHRI - R4 - Health Inequities and Societal Participation, Metamedica
Jazyk:	angličtina
Rok vydání:	2021
Předmět:	medicine.medical_specialty Tuberculosis business.industry medicine wf_220 Nucleic Acid Amplification Tests Pharmacology (medical) wf_200 Drug resistance Intensive care medicine medicine.disease business Health equity
Zdroj:	Cochrane Database Syst Rev Cochrane Database of Systematic Reviews, 2021(9):CD014877. Wiley
ISSN:	1465-1858 1469-493X
Popis:	Objectives\ud This is a protocol for a Cochrane Review (qualitative). The objectives are as follows:\ud \ud To synthesize end‐user and professional user perspectives and experiences with low‐complexity nucleic acid amplification tests (NAATs) for detection of tuberculosis and tuberculosis drug resistance.\ud \ud Review question\ud What are the perspectives and experiences of people providing and receiving low‐complexity NAATs to diagnose tuberculosis and tuberculosis drug resistance?\ud \ud Answering this question will allow us to identify the implications for effective implementation and health equity.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f09c4766b735933e07df5b3655dbb180 https://europepmc.org/articles/PMC8543783/ Zobrazit plný text záznamu